News

Absence of agreed-on FDA guidance keeps biosimilars off the US market even as their use grows abroad

Three times as many manufacturers expect more 3PL use as expect less; 38% see no change

Postponement of public data for six months is justified by slow rollout of CMS rules, they say

MedVantx pursues manufacturers looking for alternative distribution channels

Blackstone Group-owned CDMO nets over $800 million

Battlefield over drug pricing and availability continues to widen between plan managers and pharma

Outsourced contract-administration provider highlights growth in invoicing and financial stewardship burdens

First to gain newly established program reviewing therapy management and chronic care

Amped-up financial transactions continue to roil the industry as Amgen announces a big layoff

Vaccine working group tries to build consensus on temperature control and dispensing practices

Adds drug development services to its clinical, commercial packaging

Biosimilar filgrastim is already broadly marketed outside the US

Rogue online pharmacies are going the brick-and-mortar route

Generics association ramps up criticism of brand owners' tactics to delay generic introductions

US drug-wholesaling leader has 'never had a true 3PL offering'--but that changes now

Latest ZS AccessMonitor asks, 'Who are [physicians] listening to?'

Latest version is 'based on our evolving understanding of the DSCSA'

Dispute continues the ongoing battles between drug distributors and DEA

Siren Interactive hires more executives, moves to downtown Chicago

After patent expiries, 'The industry has turned a corner'

Family of GTS Carry Packs handles drugs that patients self-administer

Speedy delivery to hospitals and clinics is the goal

Cloud-based system automatically collects and analyzes company’s datalogger outputs

Meanwhile, competitor CSafe Global broadens its containers' usability

Pharma distributors and dispensers worry about more opioid abuse

Looking for the 'golden record' of physician demographics

Ongoing brand monitoring needs to be managed more holistically

Deloitte veteran is a board director of the company

The hope is that NABP's oversight will limit illicit online-pharmacy activity

European consumers will eventually have a pan-European method of checking pharmacy legitimacy